SCHEMBL1630209

SCHEMBL1630209

O=S(=O)(Nc1ccc(F)cc1)c1cc(-c2ccnn2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.49
HSD17B3 P37058 1/20 0.40
HSD17B2 P37059 1/20 0.40
NR3C2 P08235 2/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ACLY P53396 2/20 0.37
THRB P10828 1/20 0.37
PKLR P30613 1/20 0.37
HSP90AB1 P08238 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630205 0.92 HSP90AA1 (0.50) HSP90AA1NR3C2ALDH1A1KDM4EMAPT
SCHEMBL1629233 0.90 HSP90AA1 (0.48) HSP90AA1NR3C2MEN1KMT2ASMN1; SMN2
SCHEMBL1629899 0.90 HSP90AA1 (0.48) HSP90AA1NR3C2ALDH1A1KDM4EMEN1
SCHEMBL1629182 0.86 HSP90AA1 (0.49) HSP90AA1NR3C2KDM4ESMN1; SMN2ACLY
SCHEMBL1629228 0.85 ALDH1A1 (0.47) HSP90AA1NR3C2ALDH1A1KDM4EMEN1
SCHEMBL15049727 0.84 HSP90AA1 (0.53) HSP90AA1NR3C2LMNAHTTACLY
SCHEMBL1628662 0.83 LMNA (0.45) ALDH1A1GAAMEN1LMNAMAPT
SCHEMBL1631609 0.81 HSP90AA1 (0.55) HSP90AA1NR3C2ALDH1A1KDM4EMEN1
SCHEMBL1629197 0.81 ALPL (0.45) HSP90AA1ALDH1A1NPC1MAPTACLY
SCHEMBL1629125 0.80 HSP90AA1 (0.53) HSP90AA1NR3C2GAALMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885HSD17B3 1237/4885HSD17B2 1504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.